Medicine and Health

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial

H. R. C. Shanks, K. Chen, et al.

Exciting research by Hayley R. C. Shanks and colleagues investigates the p75 neurotrophin receptor in Alzheimer's disease, revealing that the novel small molecule LM11A-31 potentially slows the disease's progression, despite no significant cognitive improvements. This work opens new avenues for treatment exploration.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Effects of Nordic walking in Alzheimer's disease: A single-blind randomized controlled clinical trial

A. Angiolillo, D. Leccese, et al.

Medicine and Health

RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial

R. Wittoek, G. Verbruggen, et al.

Medicine and Health

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

A. J. Sanyal, L. M. Kaplan, et al.

Medicine and Health

A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease

R. Cheng, L. Wang, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny